Perceptive LIFE Sciences Master FUND Ltd., 10% Owner at Acrivon Therapeutics, Inc. (ACRV), bought 2,353,000 shares at $8.50 ($20.0M) on 2024-04-11, disclosed to the SEC on 2024-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ATXS | BUY | 2023-10-18 | $14.0M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |